In the armamentarium of systemic antimicrobials used to treat the more severe forms of acne, minocycline holds a prominent position. Generally considered more effective than the first-line antibiotics, tetracycline and erythromycin,1-3 minocycline is often administered at various dosages over relatively long periods of time to patients with acne who have not responded to more conservative regimens. A small number of these patients may eventually exhibit the unique, yet dramatic, complication of darkly pigmented staining of various body tissues, especially the skin.
Since it was brought to the attention of the medical community in 1978,4-6 minocycline-related pigmentation of the skin has been described in a variety of forms, and involvement of other organs has been reported as well. The finding of particles with positive iron-staining characteristics within macrophages in the affected tissue has been a consistent observation of most investigators and has been reproduced in the sophisticated studies of
Basler RSW. Minocycline-Related Hyperpigmentation. Arch Dermatol. 1985;121(5):606–608. doi:10.1001/archderm.1985.01660050058015
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.